Nanomaterials-based vaccines to target intracellular bacterial pathogens

Keyphrases

• Immunization 100%
• Intracellular Bacterial Pathogens 100%
• Nanomaterials 100%
• Humoral Immune Response 50%
• Immunogenicity 50%
• New Antigens 50%
• Live Attenuated 50%
• Vaccine Development 50%
• Intracellular Bacteria 50%
• Antigen Presentation 50%
• Infectious Virus 50%
• Cell-mediated Immune Response 50%
• In Vivo Model 50%
• Viral Pathogens 50%
• Vaccine Platform 50%
• Infectious Agents 50%
• Improved Survival 50%
• Bacterial Pathogens 50%
• Nanotechnology 50%
• COVID-19 50%
• RNA-based 50%
• Adjuvant Formulation 50%
• Traditional Vaccines 50%
• Delivery System 50%
• Novel Nanoparticles 50%
• Survival Outcomes 50%
• Intracellular Niche 50%
• Infectious Bacteria 50%
• Global Health Priorities 50%
• Carrier System 50%
• Nanoparticle-based Vaccine 50%
• Tunable Properties 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Infectious Agent 100%
• Nanomaterial 100%
• Immunogenicity 25%
• Adjuvant 25%
• Vaccine Development 25%
• Intracellular Bacterium 25%
• Virus Infectivity 25%
• SARS Coronavirus 25%
• Nanoparticle 25%

Immunology and Microbiology

• Infectious Agent 100%
• Humoral Immunity 25%
• Adoptive Immunity 25%
• Virus Infectivity 25%
• Adjuvant 25%
• Immunogenicity 25%
• Intracellular Bacterium 25%
• Antigen Presentation 25%
• Severe Acute Respiratory Syndrome Coronavirus 2 25%